{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-24-001541","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2024-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.234402+00:00","generated_at":"2026-05-30T12:44:33.608169+00:00","sec_items":["5.08"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Lexaria Bioscience sets Jan 14, 2025 annual/special meeting; director nomination deadline Nov 25","bullets":["Joint Annual and Special Meeting scheduled for January 14, 2025.","Stockholder approval required for Private Placement Warrants issued in October 2024.","Director nominee submissions due by noon ET on November 25, 2024, to Vanessa Carle.","Submission address: vcarle@lexariabioscience.com; Schedule 14N required."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-24-001541","json":"https://secwatch.observer/filing/0001640334-24-001541.json","markdown":"https://secwatch.observer/filing/0001640334-24-001541.md","text":"https://secwatch.observer/filing/0001640334-24-001541.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033424001541/0001640334-24-001541-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033424001541/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:44:33.608169+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}